Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BGXX |
---|---|---|
09:32 ET | 100 | 0.069 |
09:33 ET | 1995 | 0.069 |
09:46 ET | 239 | 0.08 |
10:13 ET | 150 | 0.08345 |
11:09 ET | 770 | 0.0825 |
11:16 ET | 100 | 0.08185 |
11:36 ET | 220 | 0.085 |
11:39 ET | 3000 | 0.0737 |
11:52 ET | 10961 | 0.085 |
11:54 ET | 3000 | 0.0738 |
11:59 ET | 2315 | 0.0738 |
01:22 ET | 2000 | 0.079575 |
03:35 ET | 64614 | 0.08 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Bright Green Corp | 15.3M | -1.6x | --- |
Gelteq Ltd | 17.3M | -11.4x | --- |
Eyenovia Inc | 9.3M | -0.1x | --- |
NDT Pharmaceuticals Inc | 9.5M | --- | --- |
China Health Industries Holdings Inc | 21.3M | -15.6x | --- |
Coeptis Therapeutics Holdings Inc | 8.0M | -0.6x | --- |
Bright Green Corporation is a producer and manufacturer of plant-based drugs and active pharmaceutical ingredients (APIs). The Company specializes in the research, production, distribution, and advancement of plant-based drugs and APIs, including psilocybin, psilocyn, peyote, and opium poppy. It plans to focus on the development of cannabis strains and sales of cannabis and hemp products with high contents of cannabinol (CBN) and cannabigerol (CBG). It also plans to cultivate cannabis and focus on the production of dried flowers, and oils and marijuana extracts. In addition to cannabis, it also has a separate area for controlled substance cactus cultivation, and a separate controlled area for mushroom propagation. It is in the process of completing construction of the 22-acre existing greenhouse to comply with the requirements for Schedule I and Schedule II plant-based drugs. It also plans to construct two new 57-acre greenhouses, one each on the Candelaria property and Azuz property.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 191.6M |
Bright Green Corp does not pay a dividend. | |
Beta | --- |
EPS | $-0.05 |
Book Value | $0.06 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.